Baker Bros. Advisors LP 13D and 13G filings for Madrigal Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-03-25 4:28 pm Purchase |
2024-03-21 | 13D | Madrigal Pharmaceuticals, Inc. MDGL |
Baker Bros. Advisors LP | 2,070,544 9.990% |
82,842 (+4.17%) |
Filing |
| 2023-11-21 5:24 pm Sale |
2023-11-17 | 13D | Madrigal Pharmaceuticals, Inc. MDGL |
Baker Bros. Advisors LP | 1,987,702 9.990% |
-28,058 (-1.39%) |
Filing |
| 2023-10-05 4:36 pm Purchase |
2023-10-03 | 13D | Madrigal Pharmaceuticals, Inc. MDGL |
Baker Bros. Advisors LP | 2,015,760 9.990% |
470,647 (+30.46%) |
Filing |
| 2023-08-08 5:16 pm Unchanged |
2023-08-07 | 13D | Madrigal Pharmaceuticals, Inc. MDGL |
Baker Bros. Advisors LP | 1,545,113 8.400% |
0 (Unchanged) |
Filing |
| 2023-06-16 7:18 pm Unchanged |
2023-06-15 | 13D | Madrigal Pharmaceuticals, Inc. MDGL |
Baker Bros. Advisors LP | 1,545,113 8.400% |
0 (Unchanged) |
Filing |
| 2023-02-14 4:00 pm Purchase |
2022-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL |
Baker Bros. Advisors LP | 1,545,113 9.000% |
45,900 (+3.06%) |
Filing |
| 2021-02-16 4:58 pm Purchase |
2020-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL |
Baker Bros. Advisors LP | 1,499,213 9.700% |
329,935 (+28.22%) |
Filing |